Comparable Effects Of Regular Treatment With Combination Of Salmeterol/fluticasone Propionate And Long-Acting Beta2-Agonist In Cough Variant Asthma

被引：0

作者：

Tagaya, E. ^{[1
]}

Okude, A. ^{[1
]}

Akaba, T. ^{[1
]}

Kirishi, S. ^{[1
]}

Kondo, M. ^{[1
]}

Isono, K. ^{[2
]}

Tamaoki, J. ^{[1
]}

机构：

[1] Tokyo Womens Med Univ, Tokyo, Japan

[2] Nishi Sayama Hosp, Saitama, Japan

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A1351

引用

页数：1

共 50 条

[41] Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease
Samp, Jennifer C.
Joo, Min J.
Schumock, Glen T.
Calip, Gregory S.
Pickard, A. Simon
Lee, Todd A.
PHARMACOTHERAPY, 2017, 37 (04): : 447 - 455
[42] Erratum to: Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases
Kai M. Beeh
Jutta Beier
Advances in Therapy, 2009, 26 : 812 - 812
[43] An antiinflammatory effect of salmeterol, a long-acting β2 agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma
Li, X
Ward, C
Thien, F
Bish, R
Bamford, T
Bao, XH
Bailey, M
Wilson, JW
Walters, EH
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (05) : 1493 - 1499
[44] Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD)
Ni, Han
Moe, Soe
Soe, Zay
Myint, Kay Thi
Viswanathan, K. Neelakantan
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (12):
[45] Combination therapy with a long-acting β2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma
Lee, DKC
Currie, GP
Lipworth, BJ
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (03) : 410 - 411
[46] Effects of adding a leukotriene antagonist or a long-acting beta2-agonist in asthmatic patients with the glycine-16 beta2-adrenoceptor genotype
Lipworth, BJ
Dempsey, OJ
Aziz, I
Wilson, AM
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (02): : 114 - 121
[47] Transcriptome-Level Interactions Between Glucocorticoid and Long-Acting Beta2-Agonist in Bronchial Epithelial Cells: Insights as to Therapeutic Efficacy in Asthma
Newton, R.
Mostafa, M. M.
Rider, C. F.
Wathugala, N. D.
Leigh, R.
Giembycz, M. A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[48] Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination vs. high doses of ICS: efficacy and safety in patients (pts) with uncontrolled occupational asthma
Gashynova, Kateryna
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[49] SALMETEROL - A 4 WEEK STUDY OF A LONG-ACTING BETA-ADRENOCEPTOR AGONIST FOR THE TREATMENT OF REVERSIBLE AIRWAYS DISEASE
DAHL, R
EARNSHAW, JS
PALMER, JBD
EUROPEAN RESPIRATORY JOURNAL, 1991, 4 (10) : 1178 - 1184
[50] Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting beta 2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate
Wolthers, Ole D.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2015, 9 (02) : 144 - 150

← 1 2 3 4 5 →